Improving profitability trend continues this year
– Inderes
Tämä sisältö on vain Inderes Premium -käyttäjille.
We upgrade our recommendation for Okmetic to Buy (Accumulate) and raise our target price to 8.0 EUR (7.7 EUR) after a solid Q4-report. Okmetic’s investment case is based on Okmetic’s solid long term growth fundamentals, improving profitability trend, low earnings based valuation (P/E 13x) and strong...
Inderes Premium
Tämä sisältö on vain Inderes Premium -käyttäjille.